Includes: Base Screen Panel – common basic drugs (non inclusive list) • Fluoxetine •… and 5 more items

The Virginia Department of Health awarded a contract to NMS Labs (Purchase Order 05471080) on September 16, 2026, for toxicology testing services. The cumulative contract value is $2,543.00. Services are to be delivered to Pamela Blizzard and include a base screening panel for common basic drugs encompassing fluoxetine, chlorpheniramine, propoxyphene, mirtazapine, sertraline, diltiazem, bupropion, ketamine, fluvoxamine, doxylamine, brompheniramine, doxepin, paroxetine, and trazodone (2 tests at $292 each).

The contract further specifies specialized blood testing services including mitigation testing ($139), an NMS Total Tox Panel for forensic purposes ($595), psilocybin qualitative analysis ($490), synthetic cannabinoids screening ($298), and loperamide and metabolite analysis ($437). All line items are designated for delivery to the same recipient and represent non-catalog items except for the base screening panel. These testing services support the Department of Health's analytical laboratory capabilities for forensic and clinical toxicology purposes.